Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study

被引:174
作者
Kontopantelis, Evangelos [1 ]
Reeves, David [2 ]
机构
[1] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Hlth Sci Primary Care Res Grp, Manchester M13 9PL, Lancs, England
基金
英国医学研究理事会;
关键词
meta-analysis; non-normal; profile likelihood; power; coverage; simulation; DerSimonian-Laird; Biggestaff-Tweedie; Sidik-Jonkman; permutations; HETEROGENEITY VARIANCE; TESTS; MODELS;
D O I
10.1177/0962280210392008
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Meta-analysis (MA) is a statistical methodology that combines the results of several independent studies considered by the analyst to be 'combinable'. The simplest approach, the fixed-effects (FE) model, assumes the true effect to be the same in all studies, while the random-effects (RE) family of models allows the true effect to vary across studies. However, all methods are only correct asymptotically, while some RE models assume that the true effects are normally distributed. In practice, MA methods are frequently applied when study numbers are small and the normality of the effect distribution unknown or unlikely. In this article, we discuss the performance of the FE approach and seven frequentist RE MA methods: DerSimonian-Laird, Q-based, maximum likelihood, profile likelihood, Biggerstaff-Tweedie, Sidik-Jonkman and Follmann-Proschan. We covered numerous scenarios by varying the MA sizes (small to moderate), the degree of heterogeneity (zero to very large) and the distribution of the effect sizes (normal, skew-normal and 'extremely' non-normal). Performance was evaluated in terms of coverage (Type I error), power (Type II error) and overall effect estimation (accuracy of point estimates and error intervals).
引用
收藏
页码:409 / 426
页数:18
相关论文
共 42 条
  • [1] Aitkin M, 1999, STAT MED, V18, P2343, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2343::AID-SIM260>3.0.CO
  • [2] 2-3
  • [3] [Anonymous], 1976, Educational Researcher, DOI [DOI 10.3102/0013189X005010003, DOI 10.2307/1174772, 10.3102/0013189x005010003, 10.2307/1174772ISSN0536-1036]
  • [4] Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.3.CO
  • [5] 2-7
  • [6] Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator
    Böhning, D
    Malzahn, U
    Dietz, E
    Schlattmann, P
    Viwatwongkasem, C
    Biggeri, A
    [J]. BIOSTATISTICS, 2002, 3 (04) : 445 - 457
  • [7] A comparison of statistical methods for meta-analysis
    Brockwell, SE
    Gordon, IR
    [J]. STATISTICS IN MEDICINE, 2001, 20 (06) : 825 - 840
  • [8] Cochran W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102
  • [9] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [10] Meta-analysis - Potentials and promise
    Egger, M
    Smith, GD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7119): : 1371 - 1374